Gaucher disease: a model disorder for biomarker discovery

Rolf G Boot, Mariëlle J van Breemen, Wouter Wegdam, Richard R Sprenger, Shreyas de Jong, Dave Speijer, Carla E M Hollak, Laura van Dussen, Huub C J Hoefsloot, Age K Smilde, Chris G de Koster, Johannes P C Vissers, Johannes M F G Aerts

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Gaucher disease is an inherited lysosomal storage disorder, characterized by massive accumulation of glucosylceramide-laden macrophages in the spleen, liver and bone marrow as a consequence of deficient activity of glucocerebrosidase. Gaucher disease has been the playground to develop new therapeutic interventions such as enzyme-replacement therapy and substrate-reduction therapy. The availability of these costly therapies has stimulated research regarding suitable biomarkers to monitor onset and progression of disease, as well as the efficacy of therapeutic intervention. Given the important role of storage cells in the pathology, various attempts have been made to identify proteins in plasma or serum reflecting the body burden of these pathological cells. In this review, the existing data regarding biomarkers for Gaucher disease, as well as the current application of biomarkers in clinical management of Gaucher patients are discussed. Moreover, the use of several modern proteomic technologies for the identification of Gaucher biomarkers is reviewed.
Original languageEnglish
JournalExpert Review of Proteomics
Volume6
Issue number4
Pages (from-to)411-9
Number of pages8
ISSN1478-9450
DOIs
Publication statusPublished - 1. Aug 2009

Fingerprint

Dive into the research topics of 'Gaucher disease: a model disorder for biomarker discovery'. Together they form a unique fingerprint.

Cite this